North America Tissue Processing Systems Market is expected to reach US$ 252.56 million by 2027


PRESS RELEASE BY The Insight Partners 10 Feb 2021

Share this press on


Tissue transfer processors segment by product is estimated to lead the market growth during the forecast period

According to The Insight Partners market research study of “North America Tissue Processing Systems Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product, Volume, End User and Country.” The North America tissue processing systems market is expected to reach US$ 252.56 million in 2027 from US$ 167.72 million in 2019. The market is estimated to grow with a CAGR of 5.4% from 2020 to 2027. The report highlights trends prevailing in the North America tissue processing systems market and the factors driving market along with those that act as hindrances.

The North America tissue processing systems market, by product, is segmented into tissue transfer processors and fluid transfer processors. The fluid transfer processors segment held the largest share of the market in 2019, whereas the tissue transfer processors segment is anticipated to register the highest CAGR in the market during the forecast period. Tissue processing involves preparing tissues for microscopic analysis by putting them in a tangible medium. It helps provide skinny and high-quality slices that can be mounted on the glass slides and properly stained to indicate normal and abnormal structures. Tissue processing systems are widely used in cancer diagnostic laboratories, where biopsy samples are processed for cancer diagnosis. The growing aging population, prone to chronic diseases such as cancer, drives the demand for regular diagnostic tests. As per estimates revealed by the National Cancer Institute, in the US, the rate of new cancer cases was 442.4 per 100,000 men and women per year, and the cancer death rate was 158.3 per 100,000 men and women per year during 2013–2017. Thus, the growing prevalence of cancer is likely to boost the demand for tissue processing products in cancer diagnosis. Also, the growing network of diagnostic laboratories in North America is favoring the growth of the market in this region.

The growth of the North America tissue processing systems market is attributed to key driving factors such as rising prevalence of cancer and increasing number of diagnostic laboratories across globe. However, high cost of cancer diagnostics is expected to restrict the market growth during the forecast period.

MiltenyiBiotec, Leica Biosystems Nussloch GmbH (Danaher) and BioGenex are among the leading companies operating in the North America tissue processing systems market.

North America Tissue Processing Systems, By Country (% Share)

North America Tissue Processing Systems, By Country (% Share)


North America Tissue Processing Systems Market to Grow at a CAGR of 5.4% to reach US$ 252.56 million from 2020 to 2027

Download Free Sample

North America Tissue Processing Systems Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Tissue transfer processors, Fluid transfer processors); Volume (Small Volume Processors, Medium Volume Processors, Large volume processors); End user (Hospitals, Pharmaceutical companies, Research laboratories, Others); and Country


The report segments in North America Tissue Processing Systems Market as follows:

By Product

  • Tissue transfer processors
  • Fluid transfer processors

By Volume

  • Small volume processors
  • Medium volume processors
  • Large volume processors

By End User

  • Hospitals
  • Pharmaceutical companies
  • Research laboratories
  • Others

By Country

  • US
  • Canada
  • Mexico
Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com 
Download Free PDF Brochure